Preferred Name |
Cefotaxime |
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C354 |
CAS_Registry |
63527-52-6 |
CHEBI_ID |
CHEBI:204928 |
Chemical_Formula |
C16H17N5O7S2 |
code |
C354 |
Concept_In_Subset | |
Contributing_Source |
FDA |
DEFINITION |
A third generation semisynthetic cephalosporin antibiotic with bactericidal activity. Cefotaxime inhibits mucopeptide synthesis by binding to and inactivating penicillin binding proteins thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of bacterial cell walls. This results in a reduction of cell wall stability and causes cell lysis. |
FDA_UNII_Code |
N2GI8B1GK7 |
Has_Salt_Form | |
label |
Cefotaxime |
Legacy_Concept_Name |
Cefotaxime |
PDQ_Closed_Trial_Search_ID |
39177 |
PDQ_Open_Trial_Search_ID |
39177 |
Preferred_Name |
Cefotaxime |
prefixIRI |
C354 |
prefLabel |
Cefotaxime |
Semantic_Type |
Organic Chemical Antibiotic |
UMLS_CUI |
C0007554 |
subClassOf |